Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus

European Journal of Neuroscience

Volumn 41, Issue 7, 2015, Pages 876-886

  Gonçalves, Francisco Q ^a   Pires, Johny ^a   Pliassova, Anna ^a   Beleza, Rui ^a   Lemos, Cristina ^a   Marques, Joana M ^a   Rodrigues, Ricardo J ^a   Canas, Paula M ^a   Köfalvi, Attila ^a   Cunha, Rodrigo A ^a,b   Rial, Daniel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

A1 receptors; A2B receptor; Adenosine; Hippocampus; Nerve terminal; Receptor interaction

Indexed keywords

2 CHLOROADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ACETAMIDE DERIVATIVE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; AMINOPYRIDINE DERIVATIVE; BAY 60-6583; N-(4-CYANOPHENYL)-2-(4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H-PURIN-8-YL)-PHENOXY)ACETAMIDE; PURINE DERIVATIVE; VESICULAR GLUTAMATE TRANSPORTER; XANTHINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG EFFECT; ELEVATED PLUS MAZE TEST; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; IMMUNOREACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NERVE ENDING; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; SYNAPTIC INHIBITION; SYNAPTOSOME; WORKING MEMORY; Y-MAZE TEST; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; MAZE TEST; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

2-CHLOROADENOSINE; ACETAMIDES; ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A1 RECEPTOR ANTAGONISTS; ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; AMINOPYRIDINES; ANIMALS; EXPLORATORY BEHAVIOR; GLUTAMIC ACID; HIPPOCAMPUS; MALE; MAZE LEARNING; MICE, INBRED C57BL; MICE, KNOCKOUT; PURINES; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2B; SYNAPTIC TRANSMISSION; VESICULAR GLUTAMATE TRANSPORT PROTEINS; XANTHINES;

EID: 84926407234     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12851     Document Type: Article

References (80)

1. 2 receptors. Eur. J. Pharmacol., 227, 317-324.
2. 2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression. Am. J. Physiol.-Cell Ph., 284, C696-C704.
3. Allaman, I., Belanger, M. & Magistretti, P.J. (2011) Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci., 34, 76-87.
4. Ambrósio, A.F., Malva, J.O., Carvalho, A.P. & Carvalho, C.M. (1997) Inhibition of N-, P/Q- and other types of Ca2+ channels in rat hippocampal nerve terminals by the adenosine A1 receptor. Eur. J. Pharmacol., 340, 301-310.
5. Anderson, W.W. & Collingridge, G.L. (2001) The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Meth., 108, 71-83.
6. 2B receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats. Brit. J. Pharmacol., 171, 1314-1329.
7. 2A receptor functions. J. Neurosci., 33, 11390-11399.
8. 2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. J. Immunol., 186, 2444-2453.
9. 2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci., 29, 14741-14751.
10. Canas, P.M., Simões, A.P., Rodrigues, R.J. & Cunha, R.A. (2014) Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease. Neuropharmacology, 76, 51-56.
11. 1 adenosine receptors. Mol. Pharmacol., 52, 788-797.
12. 1 receptors assemble into functionally interacting complexes. J. Biol. Chem., 276, 18345-18351.
13. 1 receptors in the rat hippocampus. Neuroscience, 138, 1195-1203.
14. 2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J. Neurochem., 112, 453-462.
15. 2b adenosine receptors can change their spots. Brit. J. Pharmacol., 159, 1595-1597.
16. 2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells. J. Neurochem., 107, 1369-1381.
17. 2b receptor. Nature, 407, 747-750.
18. 2A receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur. J. Neurosci., 34, 12-21.
19. Costes, S.V., Daelemans, D., Cho, E.H., Dobbin, Z., Pavlakis, G. & Lockett, S. (2004) Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J., 86, 3993-4003.
20. Cunha, R.A. (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int., 38, 107-125.
21. 2A receptor-mediated facilitation of plasticity. Neurochem. Int., 52, 65-72.
22. Cunha, R.A. & Agostinho, P.M. (2010) Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J. Alzheimers Dis., 20(Suppl 1), S95-S116.
23. Cunha, R.A., Vizi, E.S., Ribeiro, J.A. & Sebastião, A.M. (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J. Neurochem., 67, 2180-2187.
24. Dale, N. & Frenguelli, B.G. (2009) Release of adenosine and ATP during ischemia and epilepsy. Curr. Neuropharmacol., 7, 160-179.
25. 2a receptor antagonists prevent β -amyloid (25-35)-induced cognitive deficits in mice. Exp. Neurol., 203, 241-245.
26. Dawson, G.R. & Tricklebank, M.D. (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci., 16, 33-36.
27. Dixon, A.K., Gubitz, A.K., Sirinathsinghji, D.J., Richardson, P.J. & Freeman, T.C. (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Brit. J. Pharmacol., 118, 1461-1468.
28. Dunwiddie, T.V. & Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
29. Dunwiddie, T.V., Hoffer, B.J. & Fredholm, B.B. (1981) Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. N.-S. Arch. Pharmacol., 316, 326-330.
30. 1 receptor-mediated responses in rat hippocampus. J. Neurosci., 17, 607-614.
31. 2B adenosine receptor dampens hypoxia-induced vascular leak. Blood, 111, 2024-2035.
32. 1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol., 200, 184-190.
33. 2B receptors. Pharmacol. Rev., 49, 381-402.
34. 2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J. Neurochem., 66, 1426-1431.
35. 2B receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells. Neurochem. Int., 25, 99-102.
36. Fredholm, B.B., AP, I.J., Jacobson, K.A., Klotz, K.N. & Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
37. Fredholm, B.B., Chen, J.F., Cunha, R.A., Svenningsson, P. & Vaugeois, J.M. (2005) Adenosine and brain function. Int. Rev. Neurobiol., 63, 191-270.
38. 2B adenosine receptor. Biochem. Pharmacol., 90, 297-306.
39. 2A receptors in the control of dopamine release in the rat striatum. Brit. J. Pharmacol., 169, 1600-1611.
40. 1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci., 16, 547-550.
41. 1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. USA, 97, 8606-8611.
42. Gomes, C.V., Kaster, M.P., Tomé, A.R., Agostinho, P.M. & Cunha, R.A. (2011) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim. Biophys. Acta, 1808, 1380-1399.
43. 1 receptor. Mol. Cell. Biochem., 186, 19-25.
44. Headrick, J.P., Ashton, K.J., Rose'meyer, R.B. & Peart, J.N. (2013) Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol. Therapeut., 140, 92-111.
45. 1AR mRNA expression or G protein alpha-subunit content. J. Neurochem., 71, 221-230.
46. s proteins in type-1 cerebellar astrocytes. Glia, 26, 119-128.
47. 1 receptor. Proc. Natl. Acad. Sci. USA, 98, 9407-9412.
48. Kamikubo, Y., Shimomura, T., Fujita, Y., Tabata, T., Kashiyama, T., Sakurai, T., Fukurotani, K. & Kano, M. (2013) Functional cooperation of metabotropic adenosine and glutamate receptors regulates postsynaptic plasticity in the cerebellum. J. Neurosci., 33, 18661-18671.
49. 2+ and short-term synaptic plasticity. Nature, 371, 603-606.
50. 3H]GABA) release from rat hippocampal slices by nicotinic receptor activation. J. Pharmacol. Exp. Ther., 295, 453-462.
51. 3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur. J. Neurosci., 18, 1973-1978.
52. Lang, U.E., Lang, F., Richter, K., Vallon, V., Lipp, H.P., Schnermann, J. & Wolfer, D.P. (2003) Emotional instability but intact spatial cognition in adenosine receptor 1 knock out mice. Behav. Brain Res., 145, 179-188.
53. Latini, S. & Pedata, F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem., 79, 463-484.
54. 2B receptor and the C-terminus of different G protein alpha-subunits. Purinerg. Signal., 10, 441-453.
55. 2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J. Neurophysiol., 82, 3196-3203.
56. 1 receptor inhibition. Neuroscience, 112, 319-329.
57. 3 receptors are located in neurons of the rat hippocampus. NeuroReport, 14, 1645-1648.
58. 2, receptor blockade increases anxiety and arousal in Zebrafish. Basic Clin. Pharmacol., 109, 203-207.
59. 2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity. J. Neuroinflamm., 9, 198.
60. Monaco, J.D., Rao, G., Roth, E.D. & Knierim, J.J. (2014) Attentive scanning behavior drives one-trial potentiation of hippocampal place fields. Nat. Neurosci., 17, 725-731.
61. 2B receptor. J. Biol. Chem., 285, 39271-39288.
62. 1 adenosine receptors in DDT1MF-2 cells. Mol. Pharmacol., 52, 456-464.
63. 1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro. Eur. J. Neurosci., 20, 1197-1204.
64. Perez-Buira, S., Barrachina, M., Rodriguez, A., Albasanz, J.L., Martín, M. & Ferrer, I. (2007) Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease. Neurosci. Lett., 423, 194-199.
65. 2A receptors in the central nervous system. CNS Neurol. Disord.-Dr., 11, 664-674.
66. 1 receptors in nerve terminals and synapses of the rat hippocampus. Brain Res., 987, 49-58.
67. 2A receptors in the hippocampus and striatum of the rat. Neuroscience, 132, 893-903.
68. 2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses. Neuron, 57, 121-134.
69. Rial, D., Duarte, F.S., Xikota, J.C., Schmitz, A.E., Dafre, A.L., Figueiredo, C.P., Walz, R. & Prediger, R.D. (2009) Cellular prion protein modulates age-related behavioral and neurochemical alterations in mice. Neuroscience, 164, 896-907.
70. C) modulates ethanol-induced behavioral adaptive changes in mice. Behav. Brain Res., 271, 325-332.
71. 2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J. Neurochem., 92, 433-441.
72. Rodrigues, R.J., Canas, P.M., Lopes, L.V., Oliveira, C.R. & Cunha, R.A. (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol. Aging, 29, 1597-1601.
73. 1 receptors in rat brain by in vivo treatment with R-PIA: involvement of coated vesicles. Biochim. Biophys. Acta, 1310, 168-174.
74. 2B adenosine receptors in human mast cells. Mol. Pharmacol., 70, 727-735.
75. Sebastião, A.M. & Ribeiro, J.A. (2009) Adenosine receptors and the central nervous system. Handb. Exp. Pharmacol., 193, 471-534.
76. Sebastião, A.M., Cunha, R.A., de Mendonça, A. & Ribeiro, J.A. (2000) Modification of adenosine modulation of synaptic transmission in the hippocampus of aged rats. Brit. J. Pharmacol., 131, 1629-1634.
77. 2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation. PLoS One, 8, e80902.
78. Sweeney, M.I. (1997) Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci. Biobehav. R., 21, 207-217.
79. 2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J. Neurochem., 91, 1180-1190.
80. Zhou, A.M., Li, W.B., Li, Q.J., Liu, H.Q., Feng, R.F. & Zhao, H.G. (2004) A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci. Res., 48, 397-404.